Filed before 2025Filed 1 April 2020
Ralexar Therapeutics, Inc. has sold $4.28M so far
Ralexar Therapeutics, Inc., a pharmaceuticals company based in Encinitas, CA, has sold $4.28M so far in its equity round, according to a filing dated 1 April 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 1 April 2020
- First filed
- 4 January 2019
- Round
- Equity round (amended filing)
- Amount sold
- $4.28M
- Offering size
- $6M
- Investors so far
- 11
- Based in
- Encinitas, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 37% of the 1,744 tracked raises with an amount filed in 2020, and than 28% of the 40 in pharmaceuticals.
Ralexar Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 1 Apr 2020 | Amended filing | $4.28M | This raise |
| 4 Jan 2019 | New filing | $1.89M | This raise |
| 8 Jun 2017 | New filing | $4.15M | Another raise |
| 28 Apr 2015 | Amended filing | $10.6M | Another raise |
| 10 Jan 2014 | New filing | $5.16M | Another raise |
More with NSV on the board
- Riven Corp$4.45M
- Glydways, Inc.$60M
- Phase Four, Inc.$12.9M
- MetOx International, Inc.$1M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.